Author:
Saha Arabinda,Vats Poonam,Gurule Sanjay Jagannath,Khuroo Arshad
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science
Reference28 articles.
1. Campbell DJ, Kladis A, Duncan AM. Nephrectomy, converting enzyme inhibition, and angiotensin peptides. Hypertension. 1993;22(4):513–22.
2. Van Griensven JM, Schoemaker RC, Cohen AF, Luus HG, Seibert-Grafe M, Röthig HJ. Pharmacokinetics, pharmacodynamics and bioavailability of the ACE inhibitor ramipril. Eur J Clin Pharmacol. 1995;47(6):513–8.
3. Persson BA, Fakt C, Ervik M, Ahnoff M. Interference from a glucuronide metabolite in the determination of ramipril and ramiprilat in human plasma and urine by gas chromatography–mass spectrometry. J Pharm Biomed Anal. 2006;40(3):794–8.
4. Eckert HG, Münscher G, Oekonomopulos R, Strecker H, Urbach H, Wissmann H. A radioimmunoassay for the angiotensin converting enzyme inhibitor ramipril and its active metabolite. Arzneimittelforschung. 1985;35(8):1251–6.
5. Hajdú P, Schmidt D, Bomm M, Hack L, Keller A. Determination of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2-azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) and its hydrolysis product in serum and urine. Arzneimittelforschung. 1984;34(10B):1431–5.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献